CHARLOTTESVILLE, Va. (WVIR) – A new drug working to treat Parkinson’s disease has been submitted for FDA approval.
“We think it’s going to totally change the long-term fate of Parkinson’s patients,” said Richard Mailman, professor of pharmacology and neuroscience with the University of Virginia School of Medicine.
Mailman has been involved in the development of tavapadon for decades, working alongside researchers, pharmaceutical developers, and physicians to expand treatment options for Parkinson’s…